Jingchuan "Serena" Guo

Jingchuan "Serena" Guo, M.D., Ph.D.

Assistant Professor

Department: Pharmaceutical Outcomes & Policy
Business Phone: (352) 273-6533
Business Email: guoj1@cop.ufl.edu

About Jingchuan "Serena" Guo

Dr. Guo is an Assistant Professor in the Department of Pharmaceutical Outcomes and Policy at the University of Florida. Her research is built at the intersection of epidemiology, and pharmaceutical health services and outcomes research, with focus on diabetes, cardiovascular health and social determinants of health. She uses large healthcare databases and advanced methods (e.g., machine learning, causal mediation analysis) to study the equitable delivery of high-quality care, individualized effectiveness and safety of treatment and interventions, and fairness and bias in algorithmic decision-making.

Research Profile

Open Researcher and Contributor ID (ORCID)

0000-0001-9799-2592

Publications

2021
Impact of the COVID-19 Pandemic on Global Anticoagulant Sales: A Cross-Sectional Analysis Across 39 Countries
American Journal of Cardiovascular Drugs. [DOI] 10.1007/s40256-021-00475-9. [PMID] 33768423.
2021
Newer drug treatments for type 2 diabetes.
BMJ (Clinical research ed.). 373 [DOI] 10.1136/bmj.n1171. [PMID] 33975861.
2021
Predicting Mortality Risk After a Hospital or Emergency Department Visit for Nonfatal Opioid Overdose.
Journal of general internal medicine. 36(4):908-915 [DOI] 10.1007/s11606-020-06405-w. [PMID] 33481168.
2021
The Lancet Commission on diabetes: using data to transform diabetes care and patient lives.
Lancet (London, England). 396(10267):2019-2082 [DOI] 10.1016/S0140-6736(20)32374-6. [PMID] 33189186.
2021
Using machine learning to identify diabetes patients with canagliflozin prescriptions at high-risk of lower extremity amputation using real-world data.
Pharmacoepidemiology and drug safety. 30(5):644-651 [DOI] 10.1002/pds.5206. [PMID] 33606340.
2020
Comparison of Oral Anticoagulant Use and Stroke Risk Among Older Adults Newly-Diagnosed Atrial Fibrillation Living in Urban-Versus-Rural Areas.
The American journal of cardiology. 130:64-69 [DOI] 10.1016/j.amjcard.2020.06.015. [PMID] 32680675.
2020
Costs and outcomes of “intermediate” vs “minimal” care for youth-onset type 1 diabetes in six countries.
Pediatric diabetes. 21(4):628-636 [DOI] 10.1111/pedi.12988. [PMID] 31970828.
2020
Mediation analysis for estimating cardioprotection of longitudinal RAS inhibition beyond lowering blood pressure and albuminuria in type 1 diabetes.
Annals of epidemiology. 41:7-13.e1 [DOI] 10.1016/j.annepidem.2019.12.004. [PMID] 31928894.
2020
Occupational Patterns of Opioid-Related Overdose Deaths Among Arizona Medicaid Enrollees, 2008-2017.
Journal of general internal medicine. 35(7):2210-2213 [DOI] 10.1007/s11606-020-05684-7. [PMID] 32043261.
2019
Excess mortality and cardiovascular disease risk in type 1 diabetes.
Lancet (London, England). 393(10175) [DOI] 10.1016/S0140-6736(18)33047-2. [PMID] 30860050.
2019
Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen.
Journal of the American Society of Nephrology : JASN. 30(10):2000-2016 [DOI] 10.1681/ASN.2019030218. [PMID] 31537649.
2019
Greater progression of coronary artery calcification is associated with clinically relevant cognitive impairment in type 1 diabetes.
Atherosclerosis. 280:58-65 [DOI] 10.1016/j.atherosclerosis.2018.11.003. [PMID] 30471556.
2019
Optimal Blood Pressure Thresholds for Minimal Coronary Artery Disease Risk in Type 1 Diabetes.
Diabetes care. 42(9):1692-1699 [DOI] 10.2337/dc19-0480. [PMID] 31248910.
2019
Prognostic Significance of Pulse Pressure and Other Blood Pressure Components for Coronary Artery Disease in Type 1 Diabetes.
American journal of hypertension. 32(11):1075-1081 [DOI] 10.1093/ajh/hpz099. [PMID] 31214692.
2019
Serum long-chain n-3 polyunsaturated fatty acids and aortic calcification in middle-aged men: The population-based cross-sectional ERA-JUMP study.
Nutrition, metabolism, and cardiovascular diseases : NMCD. 29(8):837-846 [DOI] 10.1016/j.numecd.2019.04.011. [PMID] 31151884.
2019
The role of coronary artery calcification testing in incident coronary artery disease risk prediction in type 1 diabetes.
Diabetologia. 62(2):259-268 [DOI] 10.1007/s00125-018-4764-2. [PMID] 30426170.
2018
Association of alcohol consumption and aortic calcification in healthy men aged 40-49 years for the ERA JUMP Study.
Atherosclerosis. 268:84-91 [DOI] 10.1016/j.atherosclerosis.2017.11.017. [PMID] 29195109.
2018
Data on alcohol consumption and coronary artery calcification among asymptomatic middle-aged men for the ERA-JUMP study.
Data in brief. 17:1091-1098 [DOI] 10.1016/j.dib.2018.02.032. [PMID] 29876466.
2018
Left ventricular systolic dysfunction predicts long-term major microvascular complication outcomes in type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications (EDC) study of childhood onset diabetes.
Journal of diabetes and its complications. 32(3):298-304 [DOI] 10.1016/j.jdiacomp.2017.12.004. [PMID] 29366734.
2017
Increased Aortic Calcification Is Associated With Arterial Stiffness Progression in Multiethnic Middle-Aged Men.
Hypertension (Dallas, Tex. : 1979). 69(1):102-108 [PMID] 27821619.
View on: PubMed
2017
Reply.
Journal of hypertension. 35(6):1326-1327 [DOI] 10.1097/HJH.0000000000001342. [PMID] 28441260.
2017
The role of initial and longitudinal change in blood pressure on progression of arterial stiffness among multiethnic middle-aged men.
Journal of hypertension. 35(1):111-117 [PMID] 27775956.
View on: PubMed
2016
Pharmacodynamics, pharmacokinetics, and safety of ticagrelor in Chinese patients with stable coronary artery disease.
British journal of clinical pharmacology. 82(2):352-61 [DOI] 10.1111/bcp.12950. [PMID] 27038001.

Grants

Jul 2021 ACTIVE
Pandemic Disruptions of Atrial Fibrillation Care
Role: Principal Investigator
Funding: UNIV OF CALIFORNIA SAN DIEGO via NATL INST OF HLTH NHLBI
Jul 2019 ACTIVE
OoR Matching Support for CTSI
Role: Project Manager
Funding: UF DIV OF SPONSORED RES MATCHING FUNDS

Contact Details

Phones:
Business:
(352) 273-6533
Emails:
Business:
guoj1@cop.ufl.edu